Ébola: caracterización, historia y manifestaciones cutáneas; lo que debemos saber
| Autor: | Verónica Vial-Letelier, Juan Eduardo Carrasco-Zuber, Marianne Kolbach |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Ebola virus business.industry Pharynx Mucocutaneous zone Outbreak General Medicine medicine.disease_cause Rash Dermatology Hemorrahagic fever medicine.anatomical_structure Ebola Epidemiology Immunology Case fatality rate medicine Natural reservoir medicine.symptom Epidemics business |
| Zdroj: | Revista médica de Chile v.143 n.11 2015 SciELO Chile CONICYT Chile instacron:CONICYT |
| ISSN: | 0034-9887 |
| DOI: | 10.4067/s0034-98872015001100010 |
| Popis: | Ebola virus (EV) is one of the most virulent human pathogens. Fruits bats are its natural reservoir, the transmission to humans is across wild animals (especially primates) and the propagation in human populations is through bodily fluid contact. The actual outbreak started in December 2013 and crossed continental borders. Up to now, there are 17,145 suspected and confirmed cases with 6,070 deaths, resulting a total case fatality rate of 35%. Clinical manifestations can be divided in 3 phases. In phase I, symptoms are similar to flu, which may appear in a range of 2 to 21 days. In phase II which occurs in over 50% of cases, visceral symptoms and mucocutaneous manifestations appear within 4 and 5 days of the onset of symptoms. The main symptoms are a macular or maculopapular non-pruritic rash, desquamation and mucosal involvement of eyes, mouth and pharynx. In phase III, recovery or death occurs. The diagnosis is made on clinical grounds, epidemiological suspicion and a positive polymerase chain reaction (PCR) test. The treatment is supportive. If there is a suspected case, it should be notified immediately and all relevant safety measures should be instituted. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|